H. Everaert

发表

Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations.

Bart Neyns, Mark De Ridder, B. Neyns, 2009, Surgical neurology.

Labelled sigma receptor ligands: can their role in neurology and oncology be extended?

A. Bossuyt, V. Caveliers, T. Lahoutte, 2001, European Journal of Nuclear Medicine.

Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma

B. Neyns, M. Ridder, J. Mey, 2017, Clinical Pharmacokinetics.

99Tcm-DMSA renal scintigraphy for acute pyelonephritis in adults: planar and/or SPET imaging?

P. Flamen, A. Bossuyt, P. Franken, 1996, Nuclear medicine communications.

An unusual cause of subtalar pain and instability: accessory calcaneus.

J. de Mey, M. De Maeseneer, H. Everaert, 2012, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.

Left ventricular ejection fraction and volumes from gated single photon emission tomographic myocardial perfusion images: Comparison between two algorithms working in three-dimensional space

A. Bossuyt, P. Franken, H. Everaert, 1997, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Single-Center Experience With Ipilimumab in an Expanded Access Program for Patients With Pretreated Advanced Melanoma

I. Salmon, B. Neyns, F. Vandenbroucke, 2013, Journal of immunotherapy.

Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab

B. Neyns, B. Bravenboer, B. Velkeniers, 2016, The Journal of clinical endocrinology and metabolism.

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

B. Neyns, A. Michotte, O. Tynninen, 2011, Journal of Neuro-Oncology.

Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis

M. de Ridder, V. Vinh-Hung, N. Nguyen, 2022, World journal of clinical oncology.

Positron Emission Tomography Scintigraphy after Thoracoscopic Talcage

M. Noppen, H. Everaert, W. Vincken, 2004, Respiration.

In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease.

G. D. De Keulenaer, P. Franken, R. Schots, 2007, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients

C. Vanhove, B. Neyns, A. Bossuyt, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

An atypical sarcoid-like reaction during anti-protein death 1 treatment in a patient with metastatic melanoma

B. Neyns, S. Aspeslagh, A. Van Binst, 2020, Melanoma research.

Factors determining altered perfusion after acute pulmonary embolism assessed by quantified single-photon emission computed tomography-perfusion scan

H. Everaert, W. Vincken, M. Meysman, 2017, Annals of thoracic medicine.

The Use of Molecular Imaging to Evaluate Radiation Fields in the Adjuvant Setting of Breast Cancer

G. Storme, V. Vinh-Hung, H. Everaert, 2008, Strahlentherapie und Onkologie.

Helical CT of Rib Lesions: A Pattern-Based Approach.

Michel Osteaux, Leon Lenchik, Johan De Mey, 2004, AJR. American journal of roentgenology.

FDG accumulation in inguinal herniation mimicking metastatic disease.

A. Bossuyt, P. Franken, J. de Mey, 2004, Clinical nuclear medicine.

Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma

C. Vanhove, T. Gevaert, N. Devoogdt, 2016, The Journal of Nuclear Medicine.

Nuclear cardiology, Part III: Scintigraphic evaluation of cardiac perfusion.

A. Maes, L. Mortelmans, P. Franken, 1998, Journal of nuclear medicine technology.

Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.

G. D. De Keulenaer, P. Franken, R. Schots, 2007, Experimental hematology.

Acquisition Parameters for First-Pass ( FPRNA ) and Equilibrium Radionuclide Angiography ( ERNA )

A. Maes, L. Mortelmans, P. Franken, 2014 .

Gated SPET myocardial perfusion acquisition within 5 minutes using focussing collimators and a three-head gamma camera

C. Vanhove, P. Franken, H. Everaert, 1998, European Journal of Nuclear Medicine.

Left ventricular ejection fraction from gated SPET myocardial perfusion studies: a method based on the radial distribution of count rate density across the myocardial wall

P. Flamen, A. Bossuyt, P. Franken, 1996, European Journal of Nuclear Medicine.

Nuclear cardiology, Part IV: Viability.

A. Maes, L. Mortelmans, P. Franken, 1999, Journal of nuclear medicine technology.

Left ventricular volumes and ejection fraction from gated SPECT myocardial perfusion studies

P. Flamen, A. Bossuyt, P. Franken, 1997 .

Low-dose dobutamine gated single-photon emission tomography: comparison with stress echocardiography

C. Vanhove, P. Franken, H. Everaert, 2000, European Journal of Nuclear Medicine.

Assessment of perfusion, function, and myocardial metabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging

C. Vanhove, P. Franken, H. Everaert, 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Effect of beta-blockade on low-dose dobutamine-induced changes in left ventricular function in healthy volunteers: assessment by gated SPET myocardial perfusion scintigraphy

C. Vanhove, P. Franken, H. Everaert, 2000, European Journal of Nuclear Medicine.

Effects of low-dose dobutamine on left ventricular function in normal subjects as assessed by gated single-photon emission tomography myocardial perfusion studies

C. Vanhove, P. Franken, H. Everaert, 1999, European Journal of Nuclear Medicine.

Cardiofocal collimators for gated single-photon emission tomographic myocardial perfusion imaging

C. Vanhove, P. Franken, J. Hamill, 1997, European Journal of Nuclear Medicine.

Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.

J. Vandemeulebroucke, P. Ros, B. Ilsen, 2014, Journal of vascular and interventional radiology : JVIR.

The utility of multimodality imaging in anaplastic thyroid carcinoma.

A. Bossuyt, B. Velkeniers, K. Poppe, 2004, Thyroid : official journal of the American Thyroid Association.

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab

B. Neyns, P. van Dam, M. Keyaerts, 2021, Cancers.

Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.

P. Flamen, A. Bossuyt, P. Franken, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Effective Treatment of Pleural Epitheloid Hemangio-endothelioma with Pazopanib: A Case Report.

H. Everaert, P. Lefesvre, D. Schallier, 2016, Anticancer research.

Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)

B. Neyns, A. Michotte, P. Theuns, 2020, Journal for ImmunoTherapy of Cancer.

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome

B. Neyns, M. Keyaerts, H. Everaert, 2021, Current oncology.

Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma.

B. Neyns, A. Michotte, P. Hau, 2015, Anticancer research.

Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients?

G. Storme, H. Everaert, A. Farrag, 2010, Nuclear medicine communications.

Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor.

B. Neyns, F. Vandenbroucke, S. Wilgenhof, 2012, Anticancer research.

Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases.

B. Neyns, M. de Ridder, J. de Mey, 2008, Anticancer research.

A phase 2 clinical trial on trametinib and low-dose dabrafenib in advanced pretreated BRAFV600/NRASQ61R/K/L wild-type melanoma (TraMel-WT): Interim efficacy and safety results.

B. Neyns, H. Everaert, G. Awada, 2021 .

Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-α-methyl tyrosine and single photon emission tomography

A. Bossuyt, T. Lahoutte, H. Everaert, 2003, Nuclear medicine communications.

Baseline biomarkers correlated with outcome in advanced melanoma treated with pembrolizumab monotherapy.

S. Ong, S. Warren, B. Neyns, 2020 .

Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

B. Neyns, M. Keyaerts, H. Everaert, 2018, Annals of Oncology.

Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.

P. Flamen, A. Bossuyt, P. Franken, 1997, Anticancer research.

Phase II trial of sunitinib malate in patients with temozolomide refractory recurrent high-grade glioma.

B. Neyns, A. Michotte, N. Nupponen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II study of axitinib versus standard of care in patients with recurrent glioblastoma.

B. Neyns, V. Verschaeve, H. Everaert, 2014 .

Clinical Translation of [68Ga]Ga-NOTA-anti-MMR-sdAb for PET/CT Imaging of Protumorigenic Macrophages

N. Devoogdt, Evangelia Bolli, K. Movahedi, 2019, Molecular Imaging and Biology.

18F-FDG PET/CT imaging of an anti-CTLA-4 antibody-associated autoimmune pancolitis

B. Neyns, S. Wilgenhof, H. Everaert, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-α-methyltyrosine SPET

C. Vanhove, A. Bossuyt, V. Caveliers, 2001, European Journal of Nuclear Medicine.

Phase II study of preoperative helical tomotherapy for rectal cancer.

D. Verellen, K. Tournel, G. Storme, 2008, International journal of radiation oncology, biology, physics.

Nuclear cardiology, Part I: Anatomy and function of the normal heart.

A. Maes, L. Mortelmans, P. Franken, 1998, Journal of nuclear medicine technology.

In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport.

A. Bossuyt, V. Caveliers, T. Lahoutte, 2001, Nuclear medicine and biology.

Longitudinal Assessment of Parotid Function in Patients Receiving Tomotherapy for Head-and-Neck Cancer

C. Vanhove, D. Verellen, K. Tournel, 2008, Strahlentherapie und Onkologie.

Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu.

I. Umelo, J. de Mey, P. in’t Veld, 2012, Lung cancer.

Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.

D. Verellen, K. Tournel, G. Storme, 2012, International journal of radiation oncology, biology, physics.

Patterns of Response in Patients with Pretreated Metastatic Melanoma who Received Ipilimumab 3 mg/kg in a European Expanded Access Program: Five Illustrative Case Reports

B. Neyns, S. Wilgenhof, H. Everaert, 2012, Cancer investigation.

The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients

T. Gevaert, B. Engels, M. de Ridder, 2018, Clinical and Translational Oncology.

A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRASQ61R/K/L Mutant Melanoma (TraMel-WT)

B. Neyns, H. Everaert, G. Awada, 2021, Cancers.

The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression.

B. Neyns, B. Ilsen, L. Decoster, 2021, Clinical lung cancer.

Antitumor Activity of Cabozantinib in Metastatic Adult Ewing Sarcoma: A Case Report

H. Everaert, D. Schallier, Pierre Lesfevre, 2020, AntiCancer Research.

Can 18-FDG-PET during radiotherapy replace post-therapy scanning for detection/demonstration of tumor response in head-and-neck cancer?

G. Storme, H. Everaert, A. Farrag, 2011, International journal of radiation oncology, biology, physics.

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial

I. Salmon, S. Van Dooren, B. Neyns, 2021, Journal for ImmunoTherapy of Cancer.

Evaluation of lower back pain with bone scintigraphy and SPECT.

M. Osteaux, L. Lenchik, A. Bossuyt, 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

B. Neyns, V. del Marmol, M. Keyaerts, 2019, Journal of Translational Medicine.

Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab

G. V. van Dongen, P. Flamen, G. Ghanem, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma

I. Salmon, B. Neyns, A. Michotte, 2016, Journal of Neuro-Oncology.

Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.

A. Bossuyt, P. Franken, V. Caveliers, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Y-rituximab in CD20+ B-cell lymphoma as predicted by Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab

P. Flamen, G. Ghanem, B. Vanderlinden, 2015 .

The Impact of Accelerated HF-rTMS on the Subgenual Anterior Cingulate Cortex in Refractory Unipolar Major Depression: Insights From 18FDG PET Brain Imaging

Daniele Marinazzo, R. Raedt, Guo-Rong Wu, 2015, Brain Stimulation.

Air leaks localized with lung ventilation SPECT.

M. Keyaerts, H. Everaert, W. Vincken, 2012, Clinical nuclear medicine.

Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer

G. Vlastos, O. Ratib, M. Ridder, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Parotid gland sparing with helical tomotherapy in head-and-neck cancer.

D. Verellen, K. Tournel, G. Storme, 2012, International journal of radiation oncology, biology, physics.

Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC.

D. Verellen, K. Tournel, G. Storme, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients

A. Windhorst, N. Devoogdt, F. Duhoux, 2020, The Journal of Nuclear Medicine.

Phase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients.

V. Caveliers, T. Lahoutte, M. Keyaerts, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer

D. Verellen, G. Storme, T. Gevaert, 2012, Radiation oncology.

Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer

D. Verellen, G. Storme, T. Gevaert, 2012, Radiation Oncology.

Phase II study of helical tomotherapy for oligometastatic colorectal cancer.

B. Neyns, D. Verellen, M. Ridder, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Aspecific Uptake of 68GA-PSMA in Paget Disease of the Bone.

H. Everaert, F. De Geeter, L. Goethals, 2016, Clinical nuclear medicine.

Toxicity report of a phase 1/2 dose‐escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy

M. Ridder, K. Tournel, G. Storme, 2009, Cancer.

Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.

D. Verellen, K. Tournel, G. Storme, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PSMA Uptake in Mediastinal Sarcoidosis.

Johan De Mey, Lode Goethals, J. de Mey, 2017, Clinical nuclear medicine.

Healing Sacral Fracture Masquerading as Metastatic Bone Disease on a 68Ga-PSMA PET/CT.

Lode Goethals, Pieterjan Gykiere, Hendrik Everaert, 2016, Clinical nuclear medicine.

Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition.

B. Neyns, H. Everaert, G. Awada, 2018, Blood advances.

Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC).

B. Neyns, J. de Mey, L. Decoster, 2008, Lung cancer.

Comparison of ventilation-perfusion single-photon emission computed tomography (V/Q SPECT) versus dual-energy CT perfusion and angiography (DECT) after 6 months of pulmonary embolism (PE) treatment.

J de Mey, N Buls, J. de Mey, 2015, European journal of radiology.

Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging—initial findings

Robert Sacré, Smitha Makkat, T. Stadnik, 2006, European Radiology.

Interest of the ordered subsets expectation maximization (OS-EM) algorithm in pinhole single-photon emission tomography reconstruction: a phantom study

Michel Defrise, Frank Deconinck, Christian Vanhove, 2000, European Journal of Nuclear Medicine.

9101 Toxicity report of a phase I/II dose escalation study in inoperable locally advanced non-small cell lung cancer with helical tomotherapy and concurrent chemotherapy

G. Storme, M. Duchateau, H. Everaert, 2009 .

Preoperative [18]fluorodeoxyglucose-positron emission tomography/computed tomography in early stage breast cancer: Rates of distant metastases

C. Verschraegen, V. Vinh-Hung, N. Nguyen, 2017, World journal of radiology.

Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.

Axel Bossuyt, Tony Lahoutte, Philippe R Franken, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera

Christian Vanhove, Kristoff Muylle, Philippe R. Franken, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Automatic determination of left ventricular ejection fraction from gated blood-pool tomography.

M Defrise, P R Franken, M. Defrise, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cerebral blood flow related to induction of a depressed mood within and out of the realm of attention in normal volunteers

A. Bossuyt, H. D’haenen, R. Cluydts, 1997, Psychiatry Research: Neuroimaging.

Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial.

Thierry Gevaert, Nicolas Christian, Benedikt Engels, 2011, International journal of radiation oncology, biology, physics.

FC8 Efficiency of total body 18F PET/CT in the detection of cerebral metastases in patients with advanced melanoma

C. Vanhove, B. Neyns, M. Ridder, 2010 .

Percutaneous placement of marking coils before stereotactic radiation therapy of malignant lung lesions.

M. Noppen, D. Verellen, G. Storme, 2005, Journal of vascular and interventional radiology : JVIR.

Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series

B. Neyns, D. L. Van den Berge, L. Seynaeve, 2023, Cancers.

Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results.

A. Bossuyt, V. Caveliers, T. Lahoutte, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

I-123-IDAB: a new tracer for scintigraphic visualisation of malignant melanoma.

A. Bossuyt, H. Everaert, R. Hennekes, 1996, Bulletin de la Societe belge d'ophtalmologie.

Phase I Trial of 131 I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients

A. Windhorst, N. Devoogdt, F. Duhoux, 2021 .

Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratio

G. Storme, M. de Ridder, C. Verschraegen, 2021, Breast Cancer.

Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET.

Christian Vanhove, Dirk Verellen, Benedikt Engels, 2011, International journal of radiation oncology, biology, physics.

Nuclear cardiology, Part II: Scintigraphic evaluation of cardiac function.

A. Maes, L. Mortelmans, P. Franken, 1998, Journal of nuclear medicine technology.

Fascial Tc-99m MDP uptake in eosinophilic fasciitis as demonstrated by SPECT.

P. Flamen, A. Bossuyt, P. Franken, 1997, Clinical nuclear medicine.

Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: Long-Term Results of a Multicenter Randomized Study

T. Gevaert, B. Engels, M. de Ridder, 2023, Cancers.

Complete 18FDG positron emission tomography (PET) response after induction chemotherapy (IC) is correlated with long survival in patients (pts) with locally advanced non-small cell lung cancer (LA NSCLC).

B. Neyns, H. Everaert, C. Fontaine, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

B. Neyns, V. del Marmol, M. Keyaerts, 2019, Journal of Translational Medicine.

Tc99m-Tetrofosmin for dipyridamole stress myocardial SPECT. Intra-individual comparison with Tc99m-sestamibi

P. Flamen, A. Bossuyt, P. Franken, 1995 .

Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu.

I. Umelo, L. Decoster, E. Teugels, 2012, Lung cancer.

Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.

J. Vandemeulebroucke, P. Ros, B. Ilsen, 2014, Journal of vascular and interventional radiology : JVIR.

Focal eosinophilic hepatitis simulating a solitary metastatic lesion on FDG-PET/CT in a patient with history of head and neck cancer.

B. Ilsen, J. Mey, H. Everaert, 2011, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.

Detection of renal cortical defects.

H. Everaert, A. Piepsz, 1998, Clinical nuclear medicine.

Physiopathological Significance of 99mTc HMPAO SPECT Scan Anomalies in Chronic Fatigue Syndrome: A Replication Study

P. Flamen, A. Bossuyt, B. Fischler, 1998 .